Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
24.57
+6.05 (32.67%)
At close: Feb 20, 2026, 4:00 PM EST
24.70
+0.13 (0.53%)
After-hours: Feb 20, 2026, 7:57 PM EST

Tandem Diabetes Care Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-204.71-96.03-222.61-94.5915.57
Depreciation & Amortization
17.6716.6115.7214.3313.85
Other Amortization
1.862.092.21.91.73
Asset Writedown & Restructuring Costs
81.91-92.8531.04-
Loss (Gain) From Sale of Investments
-3.83-0.323.594.190.37
Loss (Gain) on Equity Investments
14.192.05---
Stock-Based Compensation
92.38101.3888.0884.9260.75
Provision & Write-off of Bad Debts
9.489.985.544.782.33
Other Operating Activities
4.360.240.528.562.4
Change in Accounts Receivable
-56.81-20.84.28-7.83-30.98
Change in Inventory
24.825.81-46.05-42.45-4.95
Change in Accounts Payable
2.23-2.39-4.8624.4910.28
Change in Unearned Revenue
-4.79-34.7421.538.3610.61
Change in Other Net Operating Assets
11.5240.337.4312.7829.42
Operating Cash Flow
-9.7224.23-31.8150.46111.36
Operating Cash Flow Growth
----54.68%351.41%
Capital Expenditures
-19.95-19.23-26.8-34.1-14.18
Cash Acquisitions
----25.72-
Sale (Purchase) of Intangibles
-78.59--69.5--9.33
Investment in Securities
171.41-4.2510.5692.99-163.37
Investing Cash Flow
72.88-23.48-85.7433.17-186.88
Long-Term Debt Issued
-316.25---
Long-Term Debt Repaid
-40.76-246.12---
Net Debt Issued (Repaid)
-40.7670.13---
Issuance of Common Stock
--4.1817.4751.93
Repurchase of Common Stock
-2.61-36.73---
Other Financing Activities
--25.03-0.07-0.59-
Financing Cash Flow
-43.378.374.1116.8851.93
Foreign Exchange Rate Adjustments
1.611.26-0.210.830.15
Net Cash Flow
21.410.37-113.65101.34-23.43
Free Cash Flow
-29.674.99-58.6116.3797.18
Free Cash Flow Growth
----83.16%-
Free Cash Flow Margin
-2.92%0.53%-7.84%2.04%13.83%
Free Cash Flow Per Share
-0.440.08-0.900.261.51
Cash Interest Paid
5.053.087.574.314.31
Cash Income Tax Paid
5.063.11.920.410.26
Levered Free Cash Flow
-44.7333.35-105.198.7655.93
Unlevered Free Cash Flow
-41.6535.89-101.2210.7557.98
Change in Working Capital
-23.04-11.78-17.69-4.6514.37
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q